Kara A. Trautman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kara A. Trautman has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
James W. Grier
Department of Biological Sciences, North Dakota State University, Fargo, ND, USA
2 shared publicationsKyle J Hackney
Department of Health, Nutrition, and Exercise Sciences, North Dakota State University, Fargo, ND, USA
2 shared publicationsKyle J. Hackney
Muscle, Metabolism, and Ergogenics Workgroup, Department of Health, Nutrition, and Exercise Sciences, North Dakota State University, Fargo, ND, USA
2 shared publicationsNathaniel Johnson
Department of Health, Nutrition, and Exercise Sciences, North Dakota State University, Fargo, ND, USA
2 shared publicationsSherri N. Stastny
Muscle, Metabolism, and Ergogenics Workgroup, Department of Health, Nutrition, and Exercise Sciences, North Dakota State University, Fargo, ND, USA
2 shared publicationsBryan K Christensen
North Dakota State University, PO Box 6050, Department 2620, Fargo, ND 58108
1 shared publication
Latest Publications
- 1 February 2020
- Vol. 13 (2) , 167-182
Neither a Multi-Ingredient Pre-Workout Supplement nor Caffeine Were Effective at Improving Markers of Blood Flow or Upper-Body Resistance Exercise Performance.
Few studies have measured the effects of multi-ingredient pre-workout supplements on blood flow or heart rate variability or have compared a multi-ingredient pre-workout supplement to a matched single ingredient. This study examined the effects of a multi-ingredient pre-workout supplement, an equivalent amount of caffeine, and placebo on markers of resistance training performance, blood flow, blood pressure, and heart rate variability. The study utilized a randomized, placebo-controlled, repeated-measures, crossover design. Twelve resistance-trained males (22.75 ± 4.51 yrs; 183.4 ± 7.37 cm; 91.05 ± 17.77 kg) completed the study. Resistance exercise performance was defined as total work performed during elbow flexion and extension on an isokinetic dynamometer. Blood flow was calculated using time-averaged mean velocity and blood vessel diameter of the right brachial artery, which were measured via Doppler ultrasound. Heart rate was recorded using an electrocardiogram. Neither a multi-ingredient pre-workout supplement nor caffeine alone improved upper-body resistance exercise performance or markers of blood flow relative to placebo. No differences in heart rate variability were observed across treatments. A multi-ingredient pre-workout supplement was not effective at improving performance or blood flow and did not alter autonomic nervous system function.
- 1 February 2020
- Vol. 13 (2) , 167-182
Neither a Multi-Ingredient Pre-Workout Supplement nor Caffeine Were Effective at Improving Markers of Blood Flow or Upper-Body Resistance Exercise Performance.
Few studies have measured the effects of multi-ingredient pre-workout supplements on blood flow or heart rate variability or have compared a multi-ingredient pre-workout supplement to a matched single ingredient. This study examined the effects of a multi-ingredient pre-workout supplement, an equivalent amount of caffeine, and placebo on markers of resistance training performance, blood flow, blood pressure, and heart rate variability. The study utilized a randomized, placebo-controlled, repeated-measures, crossover design. Twelve resistance-trained males (22.75 ± 4.51 yrs; 183.4 ± 7.37 cm; 91.05 ± 17.77 kg) completed the study. Resistance exercise performance was defined as total work performed during elbow flexion and extension on an isokinetic dynamometer. Blood flow was calculated using time-averaged mean velocity and blood vessel diameter of the right brachial artery, which were measured via Doppler ultrasound. Heart rate was recorded using an electrocardiogram. Neither a multi-ingredient pre-workout supplement nor caffeine alone improved upper-body resistance exercise performance or markers of blood flow relative to placebo. No differences in heart rate variability were observed across treatments. A multi-ingredient pre-workout supplement was not effective at improving performance or blood flow and did not alter autonomic nervous system function.
- Open Access
- 1 January 2020
- Published by SAGE Publications in Sage Open Medicine
- Vol. 8
What are the association patterns between handgrip strength and adverse health conditions? A topical review
Measures of handgrip strength can be used to conveniently assess overall muscle strength capacity. Although stand-alone measures of handgrip strength provide robust health information, the clinical meaningfulness to determine prevention and treatment options for weakness remains limited because the etiology of muscle weakness remains unclear. Moreover, clinical outcomes associated with handgrip strength are wide-ranging. Therefore, disentangling how handgrip strength is associated with health conditions that are metabolically or neurologically driven may improve our understanding of the factors linked to handgrip strength. The purpose of this topical review was to highlight and summarize evidence examining the associations of handgrip strength with certain health outcomes that are metabolically and neurologically driven. From this perusal of the literature, we posit that stand-alone handgrip strength be considered an umbrella assessment of the body systems that contribute to strength capacity, and a panoptic measurement of muscle strength that is representative of overall health status, not a specific health condition. Recommendations for future strength capacity–related research are also provided.
- 1 January 2020
- Published by SAGE Publications in Sage Open Medicine
- Vol. 8
Open AccessWhat are the association patterns between handgrip strength and adverse health conditions? A topical review
Measures of handgrip strength can be used to conveniently assess overall muscle strength capacity. Although stand-alone measures of handgrip strength provide robust health information, the clinical meaningfulness to determine prevention and treatment options for weakness remains limited because the etiology of muscle weakness remains unclear. Moreover, clinical outcomes associated with handgrip strength are wide-ranging. Therefore, disentangling how handgrip strength is associated with health conditions that are metabolically or neurologically driven may improve our understanding of the factors linked to handgrip strength. The purpose of this topical review was to highlight and summarize evidence examining the associations of handgrip strength with certain health outcomes that are metabolically and neurologically driven. From this perusal of the literature, we posit that stand-alone handgrip strength be considered an umbrella assessment of the body systems that contribute to strength capacity, and a panoptic measurement of muscle strength that is representative of overall health status, not a specific health condition. Recommendations for future strength capacity–related research are also provided.
- Open Access
- 28 September 2019
- Published by Oxford University Press (OUP) in Animal Frontiers
- Vol. 9 (4) , 12-17
Protein and muscle health during aging: benefits and concerns related to animal-based protein
It is estimated that by 2060, nearly one in four individuals in the United States (94 million) will be over the age of 65 (Vespa et al., 2018). A well-known consequence of aging is the loss of skeletal muscle mass and strength, which are often referred to as sarcopenia and dynapenia, respectively (Clark and Manini, 2008). Collectively, sarcopenia and dynapenia can alter energy metabolism and lead to the loss of physical function, ultimately manifesting as functional disability. Skeletal muscle wasting specifically, occurs at a rate of 1% to 2% per year beginning at age 50 yr and may significantly affect up to 45% of older adults (Baumgartner et al., 1998). For example, Figure 1 shows a magnetic resonance imaging axial scan of the left upper leg muscles in (Figure 1A) a younger, active male and (Figure 1B) an older, inactive male. When analyzed via color thresholding for various tissue types and concentrations, notice the dramatic decrease in muscular area (dark gray color) in the inactive, older adult, which is accompanied by an increase in lipid infiltration and fibrous tissue (white color) within the muscle area relative to the active, younger adult. Although this is not the same individual, it is recognized that nearly all humans will have a similar profile over time unless an intervention (physical activity, exercise, dietary, pharmacological) occurs to slow the progression of skeletal muscle loss and adipose tissue infiltration. As a result, sarcopenia may lead to a greater economic burden related to treatments associated with loss of muscle mass and physical function (Janssen et al., 2004).
- 28 September 2019
- Published by Oxford University Press (OUP) in Animal Frontiers
- Vol. 9 (4) , 12-17
Open AccessProtein and muscle health during aging: benefits and concerns related to animal-based protein
It is estimated that by 2060, nearly one in four individuals in the United States (94 million) will be over the age of 65 (Vespa et al., 2018). A well-known consequence of aging is the loss of skeletal muscle mass and strength, which are often referred to as sarcopenia and dynapenia, respectively (Clark and Manini, 2008). Collectively, sarcopenia and dynapenia can alter energy metabolism and lead to the loss of physical function, ultimately manifesting as functional disability. Skeletal muscle wasting specifically, occurs at a rate of 1% to 2% per year beginning at age 50 yr and may significantly affect up to 45% of older adults (Baumgartner et al., 1998). For example, Figure 1 shows a magnetic resonance imaging axial scan of the left upper leg muscles in (Figure 1A) a younger, active male and (Figure 1B) an older, inactive male. When analyzed via color thresholding for various tissue types and concentrations, notice the dramatic decrease in muscular area (dark gray color) in the inactive, older adult, which is accompanied by an increase in lipid infiltration and fibrous tissue (white color) within the muscle area relative to the active, younger adult. Although this is not the same individual, it is recognized that nearly all humans will have a similar profile over time unless an intervention (physical activity, exercise, dietary, pharmacological) occurs to slow the progression of skeletal muscle loss and adipose tissue infiltration. As a result, sarcopenia may lead to a greater economic burden related to treatments associated with loss of muscle mass and physical function (Janssen et al., 2004).
- 2 April 2019
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 184 (9-10) , e406-e411
Simulated Casualty Evacuation Performance Is Augmented by Deadlift Peak Force
The purpose of the current study was to examine if isometric peak force and rate of force development (RFD) were related to the ability to successfully perform a simulated casualty evacuation task in both unweighted and weighted conditions. Eighteen male participants from Army Reserve Officers’ Training Corps (ROTC) completed a maximum isometric deadlift on a force plate (IRB#HE16227). Isometric peak force and RFD were calculated from ground reaction force. Two simulated casualty evacuation performance trials were then completed. The unweighted trial consisted of lifting and carrying a 75 kg dummy as quickly as possible for 50 m. The weighted trial was similar except 9 kg vests were added to both the simulation dummy and the participant to represent 18 kg of duty gear. Independent sample t-tests and Pearson correlations were performed to compare the characteristics of those who passed and failed the weighted trial. All of the participants (n = 18) completed the unweighted casualty evacuation trial, while 72% (n = 13) were able to complete the weighted casualty evacuation trial. The participants that successfully completed the weighted evacuation trial had significantly (p < 0.05) greater isometric peak force (1420 ± 165 vs. 1076 ± 256 N) and lean mass (74.18 ± 3.89 vs. 65.34 ± 3.89 kg) when compared to participants (n = 5) that could not complete the weighted evacuating task trial. Additionally, greater Army Physical Fitness Test scores (288 ± 13 vs. 269 ± 16 arbitrary units) and significantly faster (30.34 ± 4.41 vs. 44.92 ± 10.62 seconds) unweighted evacuation trial times were observed in participants that could complete the weighted evacuation task. Peak force was also significantly correlated with lean mass (r = 0.51, p < 0.05). There was no relationship between RFD and performance of the unweighted or weight trial. Isometric deadlift peak force represents an important determinant for the success of a simulated casualty evacuation task and may be a useful marker to include in periodic fitness evaluations of military personnel.
- 2 April 2019
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 184 (9-10) , e406-e411
Simulated Casualty Evacuation Performance Is Augmented by Deadlift Peak Force
The purpose of the current study was to examine if isometric peak force and rate of force development (RFD) were related to the ability to successfully perform a simulated casualty evacuation task in both unweighted and weighted conditions. Eighteen male participants from Army Reserve Officers’ Training Corps (ROTC) completed a maximum isometric deadlift on a force plate (IRB#HE16227). Isometric peak force and RFD were calculated from ground reaction force. Two simulated casualty evacuation performance trials were then completed. The unweighted trial consisted of lifting and carrying a 75 kg dummy as quickly as possible for 50 m. The weighted trial was similar except 9 kg vests were added to both the simulation dummy and the participant to represent 18 kg of duty gear. Independent sample t-tests and Pearson correlations were performed to compare the characteristics of those who passed and failed the weighted trial. All of the participants (n = 18) completed the unweighted casualty evacuation trial, while 72% (n = 13) were able to complete the weighted casualty evacuation trial. The participants that successfully completed the weighted evacuation trial had significantly (p < 0.05) greater isometric peak force (1420 ± 165 vs. 1076 ± 256 N) and lean mass (74.18 ± 3.89 vs. 65.34 ± 3.89 kg) when compared to participants (n = 5) that could not complete the weighted evacuating task trial. Additionally, greater Army Physical Fitness Test scores (288 ± 13 vs. 269 ± 16 arbitrary units) and significantly faster (30.34 ± 4.41 vs. 44.92 ± 10.62 seconds) unweighted evacuation trial times were observed in participants that could complete the weighted evacuation task. Peak force was also significantly correlated with lean mass (r = 0.51, p < 0.05). There was no relationship between RFD and performance of the unweighted or weight trial. Isometric deadlift peak force represents an important determinant for the success of a simulated casualty evacuation task and may be a useful marker to include in periodic fitness evaluations of military personnel.
- Open Access
- 1 January 2019
- Published by International Journal of Exercise Science, L.L.C. in International Journal of Exercise Science
- Vol. 12 (2) , 701-713
Endothelial, Cardiovascular, and Performance Responses to L-arginine Intake and Resistance Exercise
International Journal of Exercise Science 12(2): 701-713, 2019. The purpose of this study was to examine the acute endothelial, cardiovascular, and performance responses to L-arginine intake by assessing flow-mediated dilation (FMD) and various indicators (e.g., heart rate, heart rate variability (HRV), blood pressure, torque) both before and after resistance exercise. Thirty (15 male, 15 female) physically active participants (mean ± SD: age 20.4 ± 1.8 years, height 176.9 ± 10.2 cm, body mass 76.0 ± 12.2 kg) volunteered for a randomized, cross-over, double-blind, placebo-controlled clinical trial. Participants completed five sets of elbow extension-flexion exercise after consumption of either 3 g L-arginine or 3 g of placebo. There was a significant decline in post-exercise elbow extension (p = 0.014) and flexion peak torque (p < 0.001). FMD response after exercise was ~5.8% less than before resistance exercise (L-arginine and placebo data pooled, p < 0.001). Baseline brachial artery diameter significantly increased post-FMD (p < 0.001), post-resistance exercise (p < 0.001), and post-resistance exercise FMD (p < 0.001). There were significant time effects for HRV when expressed as the square root of the mean of the sum of squares of differences between adjacent RR intervals (RMSSD) or the proportion of differences between adjacent normal (NN) RR intervals that exceed 50 ms (pNN50) (all p-values < 0.05), but there were no treatment or interaction effects (all p-values > 0.05). We conclude the increased vasodilation due to acute resistance exercise was not enhanced by acute supplementation with L-arginine nor was exercise performance augmented. Further, the relative contribution of sympathetic nervous system input increased with resistance exercise but was not influenced by the addition of L-arginine.
- 1 January 2019
- Published by International Journal of Exercise Science, L.L.C. in International Journal of Exercise Science
- Vol. 12 (2) , 701-713
Open AccessEndothelial, Cardiovascular, and Performance Responses to L-arginine Intake and Resistance Exercise
International Journal of Exercise Science 12(2): 701-713, 2019. The purpose of this study was to examine the acute endothelial, cardiovascular, and performance responses to L-arginine intake by assessing flow-mediated dilation (FMD) and various indicators (e.g., heart rate, heart rate variability (HRV), blood pressure, torque) both before and after resistance exercise. Thirty (15 male, 15 female) physically active participants (mean ± SD: age 20.4 ± 1.8 years, height 176.9 ± 10.2 cm, body mass 76.0 ± 12.2 kg) volunteered for a randomized, cross-over, double-blind, placebo-controlled clinical trial. Participants completed five sets of elbow extension-flexion exercise after consumption of either 3 g L-arginine or 3 g of placebo. There was a significant decline in post-exercise elbow extension (p = 0.014) and flexion peak torque (p < 0.001). FMD response after exercise was ~5.8% less than before resistance exercise (L-arginine and placebo data pooled, p < 0.001). Baseline brachial artery diameter significantly increased post-FMD (p < 0.001), post-resistance exercise (p < 0.001), and post-resistance exercise FMD (p < 0.001). There were significant time effects for HRV when expressed as the square root of the mean of the sum of squares of differences between adjacent RR intervals (RMSSD) or the proportion of differences between adjacent normal (NN) RR intervals that exceed 50 ms (pNN50) (all p-values < 0.05), but there were no treatment or interaction effects (all p-values > 0.05). We conclude the increased vasodilation due to acute resistance exercise was not enhanced by acute supplementation with L-arginine nor was exercise performance augmented. Further, the relative contribution of sympathetic nervous system input increased with resistance exercise but was not influenced by the addition of L-arginine.